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An increase in the cytoplasmic-free Ca2 concentration
mediates cellular responses to environmental signals that influ-
ence a range of processes, including gene expression, motility,
secretion of hormones and neurotransmitters, changes in
energy metabolism, and apoptosis. Mitochondria play impor-
tant roles in cellular Ca2 homeostasis and signaling, but the
roles of specific mitochondrial proteins in these processes are
unknown. Uncoupling proteins (UCPs) are a family of proteins
located in the inner mitochondrial membrane that can dissociate
oxidative phosphorylation from respiration, thereby promoting
heat production and decreasing oxyradical production. Here we
show that UCP4, a neuronal UCP, influences store-operated Ca2
entry, a process inwhichdepletionof endoplasmic reticulumCa2
stores triggers Ca2 influx through plasma membrane “store-op-
erated” channels. PC12 neural cells expressing human UCP4
exhibit reduced Ca2 entry in response to thapsigargin-induced
endoplasmic reticulum Ca2 store depletion. The elevations of
cytoplasmic and intramitochondrial Ca2 concentrations and
mitochondrialoxidative stress inducedby thapsigarginwereatten-
uated in cells expressing UCP4. The stabilization of Ca2 homeo-
stasis and preservation of mitochondrial function by UCP4 was
correlated with reduced mitochondrial reactive oxygen species
generation, oxidative stress, and Gadd153 up-regulation and
increasedresistanceof thecells todeath.ReducedCa2-dependent
cytosolicphospholipaseA2activationandoxidativemetabolismof
arachidonic acid also contributed to the stabilization ofmitochon-
drial function in cells expressing human UCP4. These findings
demonstrate that UCP4 can regulate cellular Ca2 homeostasis,
suggesting thatUCPsmay play roles inmodulatingCa2 signaling
in physiological and pathological conditions.
First identified and studied in brown fat cells, where they can
dissociate oxidative phosphorylation from respiration and
thereby promote heat production, mitochondrial uncoupling
proteins (UCPs)3 are a family of proton carrier proteins located
in the inner mitochondrial membrane (1). Five mammalian
UCPs, each with distinct tissue distributions, have been identi-
fied: UCP1 is expressed primarily in brown fat cells, UCP2 is
widely expressed, including in neurons and glial cells, UCP3 is
expressed principally in skeletal muscle cells, and UCP4 and
UCP5 (also called BMCP1) are expressed in the nervous system
(1). The functions of UCPs in neurons have not been estab-
lished, but, based on their functions in other cell types, they are
presumed tomodulate the production ofATP and reactive oxy-
gen species (ROS). One recent study showed that UCP5 is pres-
ent in neurons throughout the brain and that overexpression of
UCP5 in cultured neural cell line results in higher state 4 respi-
ration and reduced mitochondrial membrane potential and
ROS levels (2). Another study showed that levels of UCP2 are
higher in the immature brain and that high levels of UCP2 are
associated with increased resistance of neurons to seizures (3),
excitotoxicity (4), and ischemia (5). UCP2 expression is induced
by ischemic and oxidative damage (3, 5) suggesting that it may
protect neurons by functionally uncoupling mitochondria,
thereby reducing ROS production. Although the brain-specific
UCP4 was discovered more than 5 years ago (6), little is known
about its function in neurons.
The intracellular messenger Ca2 regulates many crucial
processes, including motility, secretion, gene expression, as
well as many of the signaling cascades that drive proliferation,
differentiation, and variousmetabolic reactions.Anothermajor
role for Ca2 is in cell death in physiological settings or during
injury or diseases (7, 8). The mechanisms that control cellular
Ca2 dynamics are complex, with ion channels and pumps in
the plasmamembrane and endoplasmic reticulum (ER) playing
major roles in regulating both rapid and long-term changes in
the cytoplasmic free Ca2 concentration ([Ca2]i).WhenCa2
is released from the ER Ca2 store in response to signals that
activate receptors coupled to inositol trisphosphate (IP3) pro-
duction, the emptying of the ER Ca2 stores triggers Ca2
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influx through La3-sensitive/nifedipine-insensitive Ca2-
conducting channels in the plasma membrane, a process that
has been termed store-operated Ca2 entry (SOCE) (9). In
addition to its function in refilling depleted IP3-sensitive stores,
SOCE is important for fine-tuning the transient Ca2 spikes
(10) and for inducing Ca2 dependent gene expression (11).
Though most extensively studied in non-excitable cells, SOCE
has also been described in excitable cells. Despite intensive
investigations, neither the proteins that comprise these store-
operated Ca2 channels (SOCC), nor the molecular mecha-
nisms underlying activation and gating of these Ca2 channels,
have been established. Molecular cloning and functional
expression suggest that SOCE is mediated by proteins homol-
ogous to the Drosophila transient receptor potential (TRP), a
Ca2-permeable non-selective cation channel. Mammalian
homologues of TRPs are one of the largest groups of cation
channels with diverse functions, biophysical properties, and
modes of activation (12). SOCE activation might involve dock-
ing or fusion of SOCC containing secretory vesicles with
plasma membrane, direct conformational coupling of IP3
receptors with SOCCs, or the generation and release of a dif-
fusible messenger from the ER upon depletion (13). Recent
work has identified the ER membrane-spanning STIM1 (stro-
mal interactionmolecule) as the putative ER luminal Ca2 sen-
sor that couples store depletion to SOCE activation (14).
STIM1 functionally interacts with CRACM1 (also known as
Orai1), a plasma membrane component required for SOCE
activity suggesting that the lattermay represent the SOCC itself
or a regulatory subunit of the SOCC complex (15).
Recent studies have provided evidence that mitochondria
can rapidly sequester Ca2 following its influx through SOCC
and may modulate SOCE by acting as a local buffer for Ca2
(16–19). Mitochondria are known to play key roles in the reg-
ulation of cellular Ca2 dynamics in physiological settings such
as excitation-contraction coupling and neurotransmitter
release, as well as in pathological states. Because mitochondria
play major roles in energy metabolism and production of ROS,
perturbations of mitochondrial ATP and ROS production can
affect cellular Ca2 homeostasis, and vice versa (20, 21).
Changes in mitochondrial transmembrane potential can affect
the ability of themitochondria to take upCa2, which is impor-
tant for the regulation of intramitochondrial oxidative metab-
olism (22). AlthoughUCPs have been shown tomodulatemito-
chondrial membrane potential, and ROS and ATP production,
little is known about their contribution to neuronal Ca2
homeostasis. To elucidate whether UCPsmay function in Ca2
homeostasis, we measured mitochondrial Ca2 sequestration
following IP3-dependent and independent agonist-induced
store depletion and the SOCE pathway in PC12 cells expressing
or lacking humanUCP4 (hUCP4). These data demonstrate that
hUCP4 regulates mitochondrial Ca2 sequestration and Ca2
entry but not release from intracellular stores. Furthermore,
expression of hUCP4 decreases themagnitude of sustained ele-
vation in [Ca2]i after cellular Ca2 depletion, inhibits mito-
chondrial Ca2 overload and oxidative stress, and prevents cell
death.
EXPERIMENTAL PROCEDURES
Cell Cultures and Transfection—Clones of PC12 cells stably
overexpressing full-length hUCP4 were generated using meth-
ods similar to those described previously (23). The recombi-
nant plasmid encoding full-length hUCP4 (pcDNA-hUCP4)
was kindly provided by G. Pan (Genentech). PC12 cells were
subcultured into 6-well plates coated with polyethyleneimine
and grown to 80% confluency in culture medium consisting of
Dulbecco’s modified Eagle’s medium supplemented with 10%
horse and 5% fetal bovine serum. Transfection was performed
using 1g of purified plasmid DNA and 10l of Lipofectamine
reagent (Invitrogen). Stable transfectants were obtained after
selection for growth in the presence ofGeneticin (500mg/liter).
Several clones of cells expressing moderate levels of UCP4 pro-
tein were selected and maintained in the presence of Geneticin
(200 mg/liter). For experiments, PC12 cells were plated onto
glass coverslips and used between 18 and 48 h after plating.
Transient transfection with the expression plasmid encod-
ing the mitochondrially targeted fluorescent marker DsRed
(mtDsRed) cloned into pcDNA3 (Invitrogen), was performed
using Lipofectamine.
Experimental Treatments—Undifferentiated PC12 cellswere
treated with thapsigargin (TG), N-acetyl-D-sphingosine (C2-
ceramide), C2-dihydroceramide, and aristolochic acid (Aris,
Alexis Biochemicals). All reagents except when noted were
from Sigma. When Me2SO or ethanol was used as the solvent,
their final concentration did not exceed 0.1%.At the end of each
treatment, cultures were processed for immunoblotting, and
for evaluating the extent of cell death.
Targeting 21-mer siRNA duplexes with a two-base overhang
corresponding to the Gadd153 coding regions nucleotides
270–291 (siRNAGadd153, GenBankTM accession number
NM_024134) were synthesized using the Silencer siRNA Con-
struction Kit (Ambion, Austin, TX). Briefly, sense primers and
corresponding antisense primers were mixed, heated to 95 °C
for 5min, and then allowed to cool to 25 °C at a rate of 1 °C/min
as previously described (23). Non-silencing control siRNA (siR-
NACTRL) duplexes were synthesized using scrambled
sequences. A GenBankTM search revealed no other known
genes exhibiting sequence homology to these selected target
sequences. To test the silencing effect of siRNAs on the induc-
tion of Gadd153, normal PC12 cells were transfected with the
targeting or control siRNA duplexes (100 nM) for 14 h prior to
exposure to TG. The effects of siRNA on vulnerability to TG-
induced death were evaluated after transfection of siRNAs.
RNA Isolation and RT-PCR—Total RNA was extracted from
neuronal cultures using TRIzol reagent (Invitrogen). 2g of RNA
was used for synthesis of cDNA using random primers and a first
strand synthesis kit (Invitrogen). 200 ng of the cDNAwas used in
the PCR reaction using the following pairs of primers: hUCP4: 5-
CTGGACTGGTAGCTTCTATTCTGGG-3 (forward) and 5-
TTAAAATGGACTGACTCCACTCATC-3 (reverse); rUCP2:
5-GGCTGGCGGTGGTCGGAGAT-3 (forward) and 5-CAA-
CGGGGGAGGCAATGACG-3 (reverse); rUCP4: 5-TCCTTC-
CCTGACCTCTCTTG-3 (forward)and5-TCTCCAAAGCAC-
TACAAAGTC-3 (reverse); TRPC1: 5-ACAGATGTTACAAG-
ATTTTGGG-3 (forward) and5-AACTTCCATTCTTTATCC-
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TCATG-3 (reverse); TRPC4: 5-GCCTACACCTTTCAATGT-
CATCCC-3 (forward) and 5-CTTAGGTTATGTCTCTCGG-
AGGC-3 (reverse); TRPC5: 5-CTATGAGACCAGAGC-
TATTGATG-3 (forward) and 5-CTACCAGGGAGATG-
ACGTTGTATG-3 (reverse); TRPC6: 5-GTGCCAAGTCCAA-
AGTCCCTGC-3 (forward) and 5-CTGGGCCTGCAGT-
ACGTATC-3 (reverse); and glyceraldehyde-3-phosphate dehy-
drogenase: 5-ACCACAGTCCATGCCATCAC-3 (forward)
and 5-TTGTAACCAACTGGGACGATATG-3 (reverse). The
optimized PCR conditions were 2 min at 94 °C, 35 cycles of
94 °C for 30 s, 58 °C for 30 s, 72 °C for 45 s, and 10 min at 72 °C.
ThePCRproductswere separated on a 1.5% agarose gel, stained
with ethidium bromide, and visualized using a Fuji 3000
PhosphorImager.
Immunoblot Analysis—Methods for protein quantification,
electrophoretic separation, and transfer to nitrocellulosemem-
branes were described previously (23). Membranes were incu-
bated in blocking solution (5% milk in Tween Tris-buffered
saline) overnight at 4 °C followed by a 1-h incubation in primary
antibody diluted in blocking solution at room temperature.
Membranes were then incubated for 1 h in secondary antibody
conjugated to horseradish peroxidase (Vector Laboratories),
and bands were visualized using a chemiluminescence detec-
tion kit (ECL, Amersham Biosciences). The primary antibodies
included rabbit polyclonal antibodies against hUCP4 (Alpha
Diagnostic), SERCA2 (Dr. J. Lytton, University of Calgary), cal-
reticulin (Sigma), TRPCs 1, 4, and 5 (Alomone Laboratories),
and STIM1 (Dr. J. Roos, TorreyPines Therapeutics); mouse
monoclonal antibodies against actin (Sigma), HSP60 (Signal
Transduction), cytochrome c oxidase 1 (Molecular Probes),
Bcl-2 (StressGen), Grp78 (StressGen), KDEL (StressGen), and
Gadd153 (Santa Cruz Biotechnology). Membranes were
stripped and re-probed with the actin antibody to verify and
normalize protein loading (50 g of total protein, unless stated
otherwise). To determine the presence of the mitochondria in
subcellular fractions, membranes were re-probed with the
cytochrome c oxidase 1 antibody.
Quantification of Cell Survival—Cell viability was assessed
by the trypan blue exclusion method as described previously
(23).
Confocal Laser Microscopy—Mitochondria organization was
visualized in cells transiently transfected with mitochondrially
targeted fluorescent marker DsRed as described previously
(23). Cells were illuminated 24 h post-transfection at 575 nm,
and emission was monitored at 528–633 nm.
Measurement of Mitochondrial Membrane Potential and
ROS Formation—Mitochondrial membrane potential was
determined in cultured cells using cell permeant probe tetra-
methylrhodamine (TMRE, Molecular Probes) or MitoTracker
Red CMXRos (Molecular Probes) as described previously (23).
Accumulation of TMRE in mitochondria is dependent on the
polarization state of the mitochondrial membrane. Each cul-
ture dish was incubated with 50 nM TMRE for 20 min at 37 °C
and then rinsed with Locke’s buffer (in mM: 154 NaCl, 5.6 KCl,
2.3 CaCl2, 1.0MgCl2, 3.6 NaHCO3, 5 HEPES, and 10 D-glucose,
pH 7.2). Cells were imaged using a confocal laser scanning
microscope coupled to an inverted microscope; cells were
located under bright-field optics and then scanned once with
the laser (488 nm excitation and 529 nm emission). Data were
expressed as the ratio of the change in fluorescence (dF/Fo)
after each treatment.
To assess formation of cellular ROS, cells were incubated for
30 min in the presence of the fluorescent probe dihydrorhoda-
mine 123 (10 MDHR,Molecular Probes) or 2,7-dichlorodihy-
drofluorescein diacetate (10 MDCF, Molecular Probes). DHR
localizes mainly in the mitochondria and is oxidized by several
ROS, most notably hydrogen peroxide and peroxynitrite, to the
positively charged rhodamine 123 derivative. The mitochon-
drial pixel intensity for 100 individual cells in five different
fields per culture in triplicate was averaged, and background
fluorescence was subtracted.
Measurement of Cytoplasmic and Intra-mitochondrial Free
Ca2 Concentrations—Fluorescence ratio imaging of the Ca2
indicator dye fura-2 acetylmethyl ester (fura-2/AM, Molecular
Probes) was used to quantify free intracellular Ca2 concentra-
tion ([Ca2]i) using methods detailed previously (23). Cells
were incubated for 15min in the presence of 2M fura-2/AMat
37 °C, washed twice with Locke’s buffer, and allowed to incu-
bate for 10 min before imaging. Cells were imaged using the
Zeiss Attofluor systemwith a 40 oil immersion objective lens.
The ratio of the fluorescence emission using two different exci-
tation wavelengths (340 and 380 mm) was used to determine
[Ca2]i. In some experiments Ca2 was omitted from the
Locke’s buffer without (Ca2-deficient buffer) or with 100 M
EGTA (Ca2-free buffer). Where indicated, the Locke’s buffer
was supplementedwith an appropriate amount of CaCl2. SOCE
was induced by stimulation with TG or bradykinin (BK). SKF-
96365 (Tocris) was used to blockCa2 entry, and the ionophore
4-bromo-A23187 (Calbiochem) was added to induce rapid
extrusion of Ca2 from intracellular stores out of the cell.
Ru360 (Calbiochem), a membrane-permeable analogue of
ruthenium red, was used to prevent mitochondrial Ca2
uptake.
Cells treated with 2M carbonyl cyanidem-chlorophenylhy-
drazone (CCCP, Sigma) were preincubated with 1 M oligomy-
cin to inhibit mitochondrial ATPase and thereby to protect the
cells from ATP depletion under conditions when membrane
potential was collapsed by CCCP.Mitochondrial free Ca2 lev-
els were quantified in cells loaded with the cell-permeant ace-
toxymethyl ester (AM) form of the fluorescence probe dihy-
drorhodamine-2 (Rhod-2, Molecular Probes). Cells were
incubated with 2 M Rhod-2/AM for 45 min at 37 °C and were
then washed with Locke’s buffer. Fluorescence images of ran-
domly chosen fields with 30–40 cells in each field were
acquired (excitation, 543 nm; emission, 576 nm) using a confo-
cal microscope. The laser beam intensity and photodetector
sensitivity were held constant across cultures to allow quanti-
tative comparisons of relative fluorescence intensity of cells
between treatment groups. The illumination intensity was kept
to a minimum to prevent artifactual mitochondrial Ca2 load-
ing. Control experiments were performed using CCCP with
oligomycin. Fluorescence (F) was quantified over the whole
surface of each cell body (nucleus excluded) in the selected
fields using software provided by themanufacturer (Zeiss), and
the mean intensity per cell was then calculated. Values were
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expressed as the ratio of the change in fluorescence (dF/Fo)
after each time point after treatment.
Loading and Cleavage of Bis-BODIPY-FL-C11-PC—Prepara-
tion of bis-BODIPY-FL-C11-PC (a synthetic phospholipid con-
taining fluorescein in position 2 that is dequenched upon
cleavage) in liposomes was performed according to the manu-
facturer’s specification (Molecular Probes). PC12 cells were
loaded with bis-BODIPY-FL-C11-PC for 30 min, rinsed twice
and incubated in Dulbecco’s modified Eagle’s medium for
another 30 min prior to exposure to TG. Fluorescence images
were acquired with the confocal imaging system. The data val-
ues are corrected for background fluorescence.
Statistical Comparisons—Comparisons between cell types
and treatment groups were made using analysis of variance
with Scheffe post-hoc test for pairwise comparisons.
RESULTS
hUCP4 Localizes to Mitochondria and Alters Mitochondrial
Membrane Potential—Expression of hUCP4 in stably trans-
fected PC12 cells was verified by RT-PCR and by immunoblot
analysis using a UCP4 antibody. hUCP4mRNAwas detected in
cells stably transfected with vector containing hUCP4 but not
with the empty vector (Fig. 1A, left panel). A 32-kDa immuno-
reactive band, the predicted size of UCP4, was present in whole
cell lysates and in themitochondrial
fraction of hUCP4 but not vector-
transfected (VT) cells (Fig. 1A, right
panel). A weak immunoreactive
band with a slightly higher molecu-
lar weight was present in VT cells
(indicated by the asterisk). Because
we have been unable to detect
endogenous rat UCP4 mRNA in
PC12 cells (data not shown), the
immunoreactive band is likely
UCP2, which is known to be
expressed in PC12 cells (24).
Expression of hUCP4 in PC12 cells
did not cause changes in the level of
UCP2 mRNA (Fig. 1A, left panel).
To assess the effects of hUCP4
expression on mitochondrial mem-
brane potential, we loaded cells with
low concentrations of the fluores-
cence probe TMRE. Fluorescence
imageswere acquired using a confo-
cal microscope and quantified (25).
hUCP4 cells exhibited reduced
TMRE fluorescence compared with
control cells demonstrating that
expression of hUCP4 reduces
steady-state mitochondrial mem-
brane potential (Fig. 1B), which was
sensitive to complete dissipation of
the hydrogen ion gradient induce by
the cell-permeant protonophore
CCCP. Addition of oligomycin did
not depolarize nor restore the dif-
ference in mitochondrial membrane potential suggesting that
the mitochondrial membrane potential in hUCP4 cells was not
maintained by the mitochondrial ATP synthase functioning in
reversemode and consumingATP produced by glycolysis. This
decrease in mitochondrial membrane potential led to a slight
but significant increase in oxygen consumption suggesting the
functional uncoupling activity is due to the expressed UCP4 in
PC12 (26). Furthermore, we found that intracellular ATP con-
tent was maintained suggesting no disruption in cellular ener-
getics in hUCP4-expressing cells (26). The staining pattern of
the mitochondrial targeted fluorescence marker DsREd was
similar in vector-transfected and hUCP4-expressing cells (Fig.
1C), indicating that hUCP4 expression did not grossly affect
mitochondrial distribution (Fig. 1C). Levels of cytochrome oxi-
dase (cytochrome c oxidase 1), a mitochondrial protein, remain
unchanged (Fig. 1D), indicating that hUCP4 did not induce
mitochondrial proliferation as has been reported in brain cells
of UCP2 transgenic mice (24).
hUCP4 Expression Reduces Mitochondrial Ca2 Seques-
tration—To evaluate how hUCP4 affects mitochondrial Ca2
homeostasis, we first measured the cytoplasmic free Ca2 con-
centrations in VT and hUCP4-transfected cells following stim-
ulation with the IP3 agonist bradykinin in the absence of extra-
cellular Ca2. The resting [Ca2]i level was similar in VT and
FIGURE 1. hUCP4 expression reduces mitochondrial membrane potential without affecting mitochon-
drial mass or subcellular distribution. A, the panel at the left shows the results of semi-quantitative RT-PCR
analysis of human UCP4 (hUCP4) and rat UCP2 (rUCP2) mRNAs in PC12 cell clones transfected with empty
vector (VT) or hUCP4 vector. The panel at the right shows the results of immunoblot analysis of hUCP4 protein
levels in whole cell lysates (upper blot) and in isolated mitochondria (third blot); blots were reprobed with
antibodies against either actin or heat shock protein 60 (HSP60, a mitochondrial protein) to confirm equal levels
of protein loading among samples. B, TMRE was used to measure mitochondrial membrane potential in vector-
transfected control cells (VT) and hUCP4-expressing cells. Values are the mean  S.D. of determinations made
in four separate cultures (40 – 60 cells assessed/culture); *, p  0.05. C, confocal images showing mitochondria-
associated fluorescence in VT and hUCP4 cells 36 h after transfection with the mtDsRed vector (see “Experi-
mental Procedures”). D, immunoblots showing comparable levels of mitochondrial COX-1 protein levels in VT
and in two clones of hUCP4-expressing cells.
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hUCP4-expressing cells (Fig. 2, A and B). Compared with VT
cells, the transient bradykinin-induced [Ca2]i increase in
Ca2-free buffer was higher in hUCP4 cells but did not reach
statistically significance (237  21 and 261  24 nM, respec-
tively, Fig. 2, A and B). Addition of CCCP to collapse the mito-
chondrialmembrane potential caused a transient rise in [Ca2]i
that was significantly lower in hUCP4-transfected cells com-
pared with VT cells (208  21 and 272  25 nM, respectively,
Fig. 2, A and B). Similar results were obtained when cells were
treated with TG (an inhibitor of the sarco(endo)plasmic retic-
ulum Ca2 ATPases) instead of BK (data not shown). Next, we
determined whether hUCP4 expression affects ER Ca2 store
content or release. In the presence of CCCP, the BK-induced
[Ca2]i transient was comparable in hUCP4 and VT cells
(241  20 and 231  21 nM, respectively, Fig. 2, C and D),
suggesting that hUCP4 does not affect the kinetics of agonist-
induced Ca2 release. The CCCP-induced [Ca2]i transient
was similar in VT and hUCP4 cells (121  9 and 132  11 nM,
respectively) indicating that hUCP4 expression did not signifi-
cantly alter the steady-state
[Ca2]m. We also exposed cells pre-
incubated with or without CCCP to
the Ca2 ionophore 4-bromo-
A23187 (1 M) in Ca2-deficient
buffer to assess whether hUCP4
expression may alter the ER Ca2
store. The ionophore caused rapid
extrusion of Ca2 from intracellular
stores out of the cell. In the absence
of CCCP, the ionophore-releasable
Ca2 pool was significantly lower in
hUCP4-transfected cells compared
with VT cells (Fig. 2E, upper panel;
602  34 nM and 824  23 nM,
respectively). On the other hand,
the elevation of [Ca2]i induced by
the ionophore when mitochondrial
Ca2 uptake was inhibited was not
different in hUCP4-transfected cells
compared with VT cells (Fig. 2E,
lower panel; 592 34 nM and 625
23nM, respectively). These data sug-
gest that hUCP4 expression has lit-
tle or no effect on the ER Ca2 store
content and release and that mito-
chondria in cells expressing hUCP4
have a reduced capacity to store
Ca2 that has been released from
the ER.
Evidence That hUCP4 Attenuates
the Store-operated Ca2 Entry
Pathway—Depletion of Ca2 stores
by either IP3-dependent or IP3-in-
dependent pathways results in acti-
vation of SOCE (9). Recent studies
indicate that mitochondrial Ca2
buffering is essential for SOCE and
that inhibition of mitochondrial
Ca2 uptake, either bymitochondrial depolarization or by inhi-
bition of the mitochondrial Ca2 uniporter, impairs SOCE
(16–19). Because the data above suggested that UCP4 may
affect mitochondrial Ca2 regulation, we investigated the
mechanism by which UCP4 affects the SOCE pathway. To fully
activate SOCE, we emptied intracellular stores with 1MTG in
the absence of extracellular Ca2 for 10 min. The slow and
transient increase in [Ca2]i evoked by TG due to the leak of
Ca2 from the stores was not significantly different in VT and
hUCP4-transfected cells (Fig. 3A). Subsequent exposure of cul-
tures to a range of external Ca2 concentrations ([Ca2]e)
resulted in a substantial concentration-dependent increase in
[Ca2]i, which did not return to the basal level but, instead,
decreased slowly to a steady-state level of elevated [Ca2]i. This
plateau [Ca2]i reflects the balance between Ca2 influx into
the cytosol through SOCE, which is gradually reduced by a
feedback inhibition by Ca2, and Ca2 efflux from the cells
driven mainly by plasma membrane Ca2 ATPase. Expression
of hUCP4 decreased both the peak amplitude and steady-state
FIGURE 2. hUCP4 reduces mitochondrial Ca2 sequestration following Ca2 release from internal stores.
A, recordings showing the mean [Ca2]i before and after sequential additions of 10 M bradykinin (BK) and 2 M
CCCP (plus 1.0 M oligomycin to prevent ATP depletion) to VT and hUCP4-expressing PC12 cells incubated in
Ca2 free medium. Cells were loaded with fura-2, and [Ca2]i was recorded as described under “Experimental
Procedures.” B, values of the basal [Ca2]i and the peak [Ca
2]i after exposure to BK and CCCP in VT and
hUCP4-tansfected cells. Values are the mean  S.D. of determinations made in four separate cultures (40 – 60
cells assessed/culture), *, p  0.01 compared with the value for CCCP-treated VT cells. C, recordings showing
the mean [Ca2]i before and after sequential additions of 2 M CCCP and 10 M BK to fura-2-loaded VT and
hUCP4-expressing PC12 cells incubated in Ca2-free medium. D, values of the basal [Ca2]i and the peak
[Ca2]i after exposure to CCCP and BK in VT and hUCP4-tansfected cells. Values are the mean  S.D. of deter-
minations made in four separate cultures (40 – 60 cells assessed/culture). E, recordings showing 4-bromo-
A23187-induced [Ca2]i elevation in VT and hUCP4-transfected cells that had been preincubated in the
absence (top graph) or presence (bottom graph) of CCCP. The arrow indicates time of addition of the Ca2
ionophore (1 M).
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level of [Ca2]i during the store refilling period when the
[Ca2]e was increased to 1.0 mM or greater (Fig. 3B). Following
addition of 2 mM Ca2, the average rise in [Ca2]i level was
762  56 and 553  43 nM in VT and hUCP4-transfected cells,
respectively (Fig. 3B). A [Ca2]e of 2 mM, which represents the
physiological level of extracellular calcium, was chosen for all
subsequent experiments to better appreciate differences in
Ca2 signals.
It is unlikely that hUCP4 interfered with the intensity of the
coupling signal transmitted from ER to plasma membrane
SOCC, because the initial rate of [Ca2]i change was similar in
both VT and hUCP4-expressing cells (Fig. 3A). To determine
whether hUCP4 may interfere with TG-induced depletion of
intracellularCa2 stores, we assessed the ability of BK to release
Ca2 following exposure of cells to TG. Addition of 100 M BK
failed to elicit further increase in [Ca2]i in either VT or
hUCP4-transfected cells (data not shown) suggesting that
stores were indeed fully depleted and that the reduction of
SOCE in hUCP4 cells could not be attributed to incomplete
store depletion. Preincubation of cellswith SKF-96365, awidely
employed inhibitor of SOCE, strongly inhibited TG-induced
Ca2 entry (Fig. 3C), suggesting that the rise in [Ca2]i ismainly
attributed to SOCE. To assess whether hUCP4 may enhance
Ca2 extrusion mechanisms, we added EGTA during store
refilling to abruptly inhibit Ca2 influx. The rapid decay of the
steady state [Ca2]i and hence the
initial rate of Ca2 clearance, which
mostly reflects Ca2 extrusion rate
was comparable in VT and hUCP4-
transfected cells (data not shown).
Taken together, these data support
the argument that expression of
hUCP4 diminishes mitochondrial
Ca2 sequestration and SOCE
rather than enhancing Ca2 efflux
across plasma membrane.
hUCP4 Does Not Alter Expression
of Proteins in the SOCE Pathway—
We next determined whether over-
expression of hUCP4 affects levels
of proteins involved in the SOCE
pathway. Steady-state levels of
SERCA2 and the ER luminal Ca2
binding/storage protein calreticu-
lin, two ER proteins that regulate ER
Ca2 store refilling and, indirectly,
SOCE (27) were not significantly
different in hUCP4-transfected and
VT cells (Fig. 3D). Levels of Bcl-2, a
protein that has been shown to play
a role in ER Ca2 homeostasis (28,
29), were also similar in VT and
hUCP4 cells. Because the SOCE
responsewas reduced inhUCP4cells,
wedeterminedwhether expressionof
TRP-related proteins was down-reg-
ulated in hUCP4 cells. Previous stud-
ies showed that induction of differen-
tiation and chronic hypoxia increased expression of several TRPC
proteins (a subfamily of TRPs), which was accompanied by an
increase in SOCE activity (30). PC12 cells express most of the
six TRPC (TRP 1–6) members (31). Despite their similarity in
amino acid sequence, members of the TRPC subfamily have
different modes of activation (12). Some TRPC proteins form
Ca2-permeable cation channels that do not appear to be store-
operated; they do not respond to treatment with TG, the most
selective pharmacological tool for activating SOCE. Because
store-depletion-insensitive TRPCs may heteromultimerize
with store-depletion-sensitive TRPCs to form functional
SOCC (12), we analyzed the expression of TRPs 1, 4, 5, and 6 in
VT and hUCP4-transfected cells. TRPC4 mRNA was not
detected in VT or hUCP4 cells (Fig. 3E). Steady-state levels of
TRPCs 1, 5, and 6 mRNA measured by RT-PCR were not
affected by hUCP4 expression (Fig. 3E); similarly, levels of
TRPC proteins 1 and 5 were not different in VT and hUCP4
cells. Moreover, the protein level of STIM1, the putative ER
calcium sensor (14, 15), was not different in VT and hUCP4
cells. Thus, it is unlikely that altered expression of TRPCs or
STIM1contributed to the observed effect of hUCP4 in reducing
SOCE.
hUCP4 Regulates SOCE at the Level of Mitochondrial Ca2
Sequestration—To determine whether mitochondrial Ca2
uptake is essential for maintenance of SOCE, we induced com-
FIGURE 3. Expression of hUCP4 reduces store-operated Ca2 entry. A and B, store-operated Ca2 entry was
assessed by depleting Ca2 stores with 1 M thapsigargin (TG) in Ca2-free medium for 15 min, followed by
exposure of fura-2-loaded cells to medium containing 0.5 or 2.0 mM Ca2 (upper and lower graphs in panel A,
respectively) to initiate Ca2 entry. The values in panel B are the mean  S.D. of determinations made in three
or four cultures (30 – 40 cells assessed per culture). *, p  0.05; #, p  0.01. C, preincubation of fura-2-loaded VT
and hUCP4 cells with 10 M SKF-96365 (a SOCE blocker) for 5 min markedly attenuates SOCE induced by 1 M
TG. D, immunoblot analyses showing protein levels of calreticulin, SERCA2, and Bcl-2 in VT cells and two clones
of hUCP4-transfected cells. E, RT-PCR analysis (upper panel) showing mRNA levels of TRPCs and actin, and
immunoblots (lower panels) showing protein levels of TRPCs, STIM1, and actin in one or two clones of hUCP4-
expressing cells.
Mitochondrial UCP4 Regulates Calcium Homeostasis















plete store depletion with TG in Ca2-free medium and
assessed the amount of releasable Ca2 from mitochondria
([Ca2]m) in TG-treated cells during re-application of 2 mM
Ca2. Consistent with the results above (Fig. 3, A and B), the
magnitude of the [Ca2]i rise and the average plateau Ca2
were significantly lower in hUCP4-transfected cells during
Ca2 re-application (Fig. 4A). To terminate loading, we applied
Ca2-free buffer for another 150 s. Subsequent addition of
4-bromo-A23187 released the Ca2 sequestered in the TG-in-
sensitivemitochondrial store, and the amount of released Ca2
was significantly lower in hUCP4-transfected cells than in VT
cells (918  36 versus 618  24 nM, Fig. 4A) indicating that
mitochondria of hUCP4-transfected cells take up less Ca2
during store refilling.
Next, we determinedwhether acute exposure toCCCP in the
presence of oligomycin could mimic the inhibitory action of
hUCP4 on the SOCE pathway. When CCCP was applied to
TG-treated cells 1 min prior to and during the store-refilling
period, TG-stimulated SOCE was largely blocked in both VT
and hUCP4-transfected cells (388  34 nM and 340  28 nM,
respectively, Fig. 4B). Subsequent application of 4-bromo-
A23187 in Ca2-deficient buffer released little Ca2 from the
TG-insensitive stores in VT and hUCP4-transfected cells. As
expected, CCCP applied to TG-treated cells during the store-
refilling period caused release of
Ca2 sequestered in the TG-insen-
sitive stores, and the magnitude of
this release was significantly lower
in hUCP4-transfected cells com-
pared with VT cells (719  46 and
1012 56 nM, respectively, Fig. 4C).
To verify that the TG-insensitive
Ca2 stores were mitochondria, we
loaded cells with Rhod-2/AM, a
Ca2-sensitive fluorescent indica-
tor commonly used to monitor
changes in [Ca2]m (32). The mag-
nitude of the increase in Rhod-2 flu-
orescence signal was significantly
greater in VT cells than in hUCP4
cells following the addition of TG in
the absence or presence of extracel-
lular Ca2. CCCP, which prevented
uptake of Rhod-2 into the organelle,
inhibited the increase in the fluores-
cence signal in both cell types, fur-
ther confirming that the TG-insen-
sitive store is mitochondria (Fig.
4D). To further demonstrate that
Ca2 uptake by mitochondria is
required to sustain SOCE, we used
Ru360, a membrane-permeable
analogue of ruthenium red that pre-
vents mitochondrial Ca2 uptake by
directly inhibiting theCa2uniporter
without interfering with the mito-
chondrial membrane potential (33).
Treatment with 10 M Ru360 signif-
icantly reduced SOCE in VT cells to an extent comparable to
that in hUCP cells (258  19 and 247  13 nM, Fig. 4E). As
expected, the amount of Ca2 released from the TG-insensi-
tive stores was reduced in Ru360-treated VT and hUCP4
cells upon application of 4-bromo-A23187. Collectively, our
data suggest that expression of hUCP4 attenuates the ability
of the mitochondria to sequester cytosolic Ca2 and to sus-
tain SOCE (16–19).
hUCP4 Attenuates Store Depletion-induced Cell Death—To
determine whether cells expressing hUCP4 are more resistant
to death induced by TG, we measured viabilities of VT and
hUCP4 cells exposed toTG for various time periods. Compared
with VT cells, hUCP4 cells were significantly more resistant to
death induced by TG.When exposed to TG for 24 h inmedium
containing 2mMCa2, 28% of the hUCP4-expressing cells were
dead compared with 50% of VT cells (Fig. 5A). Decreasing the
[Ca2]e to 0.5 mM protected VT cells against TG-induced
death, effectively eliminating the protective effect of hUCP4
(Fig. 5A). These findings suggested that hUCP4protects cells by
reducing SOCE. Consistent with this conclusion we found that
the L-type Ca2 channel blocker nimodipine (1 M) had no
significant effect on TG-induced death (data not shown).
Because exposure of PC12 cells to SKF-96365 or Ca2-free
medium resulted in cell death within 6–12 h (data not shown),
FIGURE 4. hUCP4 reduces mitochondrial Ca2 loading during store depletion-induced SOCE. A, record-
ings showing the mean [Ca2]i before and after exposure of fura-2-loaded VT and hUCP4 cells to the indicated
treatments (thapsigargin (TG), 1 M; 4-bromo-A23187, 10 M). B and C, recordings of [Ca2]i in fura-2-loaded VT
and hUCP4 cells exposed to the indicated treatments (TG, 1 M; 4-bromo-A23187, 1 M; CCCP, 2 M plus 1.0 M
oligomycin). D, Rhod-2 fluorescence in VT and hUCP4 cells exposed to the indicated treatments; measure-
ments were made 2 min after addition of vehicle or TG alone, or in combination with 2 mM Ca2 to induce SOCE.
Shown are the ratios of the change in fluorescence signal (relative to vehicle alone) and S.D. of measurements
made in three or four cultures (30 – 40 cells assessed per culture). *, p  0.05 and **, p  0.01 compared with
corresponding values of VT cells. E, recordings showing the mean [Ca2]i before and after exposure of fura-2-
loaded VT and hUCP4 cells to the indicated treatments (TG, 1 M; Ru360, 10 M; 4-bromo-A23187, 10 M).
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we were unable to determine their effects on TG-induced cell
death.
We found that basal and TG-induced levels of the ER chap-
erone GRP78, an indicator and key component of the ER stress
response (34), were similar in VT and hUCP4-expressing cells
(Fig. 5, B andD), indicating that hUCP4 did not protect against
TG-induced death by facilitating induction of this ER chaper-
one. In contrast, protein levels of the growth-arrest DNA dam-
age-inducible protein 153 (Gadd153), a ubiquitously expressed
member of the CAAT/enhancer-binding protein family of
transcription factors, increased more rapidly in VT compared
with hUCP4 cells (Fig. 5, B and D). Because Gadd153 is highly
induced in response to an elevation of [Ca2]i (35), its greater
increase following TG treatment in VT cells compared with
hUCP4 cells is likely due to the greater sustained elevation in
Ca2 as the result of SOCE. Reducing [Ca2]e to 0.5 mM
resulted in not only an attenuation but also a normalization of
the TG-induced increase in Gadd153 protein levels in VT and
hUCP4-expressing cells (Fig. 5, C and D). Thus, expression of
hUCP4 attenuates cell death by suppressing SOCE and the up-
regulation of Gadd153.
hUCP4 Protects against Cell Death Induced by Ceramide—
Ceramide is generated from membrane sphingomyelin in
response to activation of various cytokine receptors and by
exposure of cells to oxidative stress; ceramide can induce cell
death by activating the SOCE path-
way (36). We therefore determined
how expression of hUCP4 expres-
sionmight affect the vulnerability of
PC12 cells to ceramide-induced
death. VT and hUCP4 PC12 cells
were exposed to increasing concen-
trations of the cell-permeable cera-
mide analogue C2-ceramide, and
cell viability was determined 12 and
24 h later. Cells expressing hUCP4
were significantly more resistant to
C2-ceramide-induced death com-
pared with VT cells (Fig. 6A). The
biologically inactive stereoisomer
C2-dihydroceramide (40 M) had
no significant effect on the survival
of VT or hUCP4 cells during a 24-h
exposure period. To determine
whether the protective action of
hUCP4 was mediated by its inhibi-
tory role on the SOCE pathway, we
measured Ca2 entry in VT and
hUCP4 cells after exposure to
C2-ceramide (Fig. 6B). C2-ceramide
caused a slow rise in [Ca2]i that
reached a long-lasting plateau in
cells maintained in Ca2-contain-
ing medium; the magnitude of this
Ca2plateauwas significantly lower
in hUCP4 cells compared with VT
cells. In the absence of extracellular
Ca2, the rise in [Ca2]i was slower
and only transient in both VT and hUCP4 cells (Fig. 6B), sug-
gesting that Ca2 entry was required to maintain the Ca2 pla-
teau in cells treated with C2-ceramide. To determine whether
SOCE activity contributed to the increase in [Ca2]m in cells
treatedwithC2-ceramide, we added theCa2 ionophore 4-bro-
mo-A23187 to cells 10 min after treatment with C2-ceramide.
The rapid [Ca2]i rise upon addition of theCa2 ionophorewas
markedly reduced in hUCP4-expressing cells (645  34 nM)
comparedwith VT cells (1068 52 nM, p 0.01) (Fig. 6C). The
relative increase in the resting [Ca2]i was also much lower in
C2-ceramide-treated hUCP4-expressing cells compared with
VT cells. Reducing [Ca2]e to 0.5 mM partially protected VT
cells from death induced by C2-ceramide (data not shown).
Immunoblot analysis showed that expression of hUCP4
resulted in an attenuation of the ceramide-induced increase in
Gadd153 protein levels compared with VT cells (Fig. 6D).
hUCP4 Expression Reduces Oxidative Stress and Preserves
Mitochondrial Function—Mitochondria are a major source of
intracellular ROS production, and sustained Ca2 entry and
mitochondrial Ca2 uptake can increase mitochondrial oxida-
tive metabolism and generation of ROS. Mitochondrial ROS
are key inducers of mitochondrial transition pore opening, a
process pivotal for cell death in many physiological and patho-
logical settings. Todeterminewhether hUCP4modulatesmito-
chondrial oxidative stress, we employed DHR, a cell-permeant
FIGURE 5. hUCP4 expression protects cells against thapsigargin-induced death. A, cultures of vector-
transfected (VT) and hUCP4-expressing cells were exposed to thapsigargin (TG; 0.5 M) in medium containing
2.0 and 0.5 mM Ca2 ([Ca2]e). At the indicated time points viability was assessed by the trypan blue exclusion
method. Values are expressed as the percentage of cells that were trypan blue-positive; bars represent the
mean  S.D. of determinations made in four separate cultures (100 –150 cells assessed/culture); *, p  0.01; #,
p  0.05. Comparable results were obtained in additional experiments utilizing a different PC12 clone express-
ing hUCP4. B and C, basal and TG-induced levels of the ER stress proteins, growth-arrest DNA damage-inducible
(Gadd) 153 protein and glucose-regulated protein (Grp) 78. Whereas the TG-induced increase in GRP protein
levels were comparable, the increase in Gadd153 protein was markedly lower in hUCP4-expressing cells com-
pared with that of VT cells incubated in medium containing 2 mM (B) but not 0.5 mM Ca2 (C). Blots were
reprobed with an actin antibody to confirm equal levels of protein loading among samples. D, densitometric
analyses were performed on the immunoblots obtained from B and C in two independent studies. The ratio of
the signal of Gadd153 and GRP78 in treated cells incubated in 2.0 (top panel) and 0.5 (bottom panel) mM [Ca2]e
at each time point as indicated on the x-axis and that of actin is shown on the y-axis in arbitrary units.
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mitochondrial dye, to assess formation of mitochondrial ROS
in live cells. Exposure of VT cells to TG caused a rapid increase
in DHR fluorescence within 2 h, followed by a sustained peak
between 6 and 12 h (Fig. 7A). The increase in ROS production
was significantly smaller in hUCP4 cells demonstrating that
expression of hUCP4 suppresses mitochondrial ROS forma-
tion. The increase in DCF fluorescence, which measured cellu-
lar peroxide levels, was also reduced in hUCP4 cells at each time
point (Fig. 7A). We also monitored mitochondrial membrane
potential during an 18-h exposure to TG (Fig. 7B). The basal
membrane potential was greater in VT cells compared with
hUCP4 cells. After exposure to TG, the membrane potential in
VT cells rose to a peak level at 6 h of exposure and then
decreased to a level below the baseline at 18 h. In contrast, the
membrane potential in hUCP4 cells rose modestly through 6 h
and was maintained at this level through 18 h (Fig. 7B). A sim-
ilar pattern of increases in DHR and TMRE intensities above
the level of vehicle-treated cells was obtained in VT and hUCP4
cells exposed to C2-ceramide (data not shown).
Although mitochondria are prime targets of Ca2-mediated
apoptosis, SOCE could also contribute to Ca2-dependent
events in the cytosol that may indirectly influence mitochon-
drial function. Recent studies indicate that the extent of Ca2
entry through the SOCE pathway determines the activity of
Ca2-dependent cytosolic phospholipase A2 (cPLA2) (37).
Upon activation and translocation to intracellular membranes,
cPLA2 generates and releases arachidonic acid frommembrane
phospholipids (38). To determine
whether expression of hUCP4
reduces the generation of arachi-
donic acid, we loaded cultured cells
with the synthetic phospholipid bis-
BODIPY-FL-C11-PC, which under-
goes dequenching upon hydrolysis by
PLA2 to release the labeled phospho-
lipid within the cell. Exposure of bis-
BODIPY-FL-C11-PC-loaded cells to
TG triggered rapid phospholipid
hydrolysis as indicated by an
increased fluorescence signal (Fig.
7C). The magnitude of the TG-in-
duced lipid hydrolysis was signifi-
cantly lower, by 30%, in cells
expressing hUCP4 compared with
VT cells (Fig. 7D). Aristolochic acid,
a specific inhibitor of cPLA2, dra-
matically reduced the fluorescent
signal associated with phospholipid
release (Fig. 7 D), consistent with
the activation of cPLA2 by TG.
Incubation of cells in medium lack-
ing Ca2 also largely inhibited TG-
induced phospholipid hydrolysis
(data not shown). Because arachi-
donic acid itself, and metabolites
generated in the cyclooxygenase or
lipoxygenase pathways, can con-
tribute to oxidative stress (39), we
determined whether inhibition of cPLA2 activation blocked
ROS production. Pretreatment of cells with aristolochic acid
partially inhibited TG-induced ROS production (data not
shown), suggesting that cPLA2 and its associated metabolic
pathways contribute to oxidative stress.
Because oxidative stress can contribute to Gadd153 up-reg-
ulation (40–42) and because the magnitude of induction of
Gadd153 protein levels was significantly greater in VT com-
pared with hUCP4 cells (Fig. 5, B and D), we determined
whether suppression ofGadd153 function by RNA interference
normalized the differential vulnerability of the clones to TG-
induced death. The TG-induced increase in Gadd153 protein
was attenuated in VT and hUCP4 cells over a course of 14 h in
the presence of 100 nMGadd153 but not scrambled siRNA (Fig.
8A). Under these conditions, ER stress-induced expression of
two other ER stress proteins, Grp78 and -94, were unaffected by
the siRNA treatment. Suppression of endogenous Gadd153
expression partially rescued VT cells from TG-induced death
(Fig. 8B). In addition, knockdown ofGadd153 functionwas also
more effective compared with aristolochic acid in decreasing
the vulnerability of VT cells to TG-induced death (Fig. 8B) sug-
gesting that Gadd153 is a critical mediator of store depletion-
induced oxidative stress and death.
DISCUSSION
Mitochondria play an important role in intracellular Ca2
dynamics and signaling by sensing microdomains of both Ca2
FIGURE 6. hUCP4 expression protects against cell death induced by ceramide. A, cultures of VT and hUCP4
cells were exposed to different doses of C2-ceramide (10 and 40 M) and C2-dihydroceramide (DHC, 40 M). At
the indicated time points viability was assessed by the trypan blue exclusion method. Values are the mean 
S.D. of determinations made in four separate cultures (100 –150 cells assessed/culture); *, p  0.01 compared
with the corresponding value for VT cells. B, recordings showing the [Ca2]i in VT and hUCP4 cells following
treatment with C2-ceramide (20 M) in the absence or presence of extracellular Ca
2. Cells were loaded with
fura-2/AM as described under “Experimental Procedures.” The arrow indicates time of addition of C2-ceramide.
C, recordings showing the [Ca2]i in fura-2/AM-loaded VT and hUCP4 cells prior to and during exposure to
4-bromo-A23187 (1 M) in Ca2-free buffer. Cells were pretreated with vehicle or 20 M C2-ceramide for 10 min
prior to exposure to 4-bromo-A23187 (indicated by the arrow). D, immunoblot showing Gadd153 and GRP78
protein levels in ceramide-treated VT and hUCP4 cells. The blot was reprobed with an actin antibody to confirm
equal levels of protein loading among samples. Comparable results were achieved in experiments utilizing an
additional PC12 clone expressing hUCP4.
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release fromER stores andCa2 influx across the plasmamem-
brane (16–19). It has been shown that within these subcellular
microdomains Ca2 is efficiently taken up by mitochondria.
The ability of mitochondria to buffer Ca2 locally is essential
for gatingCa2-sensitive plasmamembrane channels.Our data
suggest that hUCP4 regulatesmitochondrial Ca2 homeostasis
and sensitivity of neural cells to store depletion-induced death
by virtue of its ability to alter the membrane potential-depend-
ent Ca2 buffering capacity of the mitochondria. The effects of
hUCP4 on SOCE and cell death were associated with decreased
levels of ROS. PC12 cells expressed little or no endogenous
UCP4, the level of UCP2 expression was low and unaffected by
expression of hUCP4, and hUCP4 had no detectable effects on
mitochondrial shape or subcellular distribution. The latter
findings suggest that the effects of hUCP4 on store depletion-
induced Ca2 entry and cell survival were not secondary to
changes in mitochondrial mass.
The key event in the SOCE pathway is intracellular Ca2
store depletion that triggers Ca2 entry upon activation of
SOCC in the plasma membrane. The magnitude of the SOCE
response is related to the degree to which stores are depleted
(9). When exposed to a concentration of TG (1 M) that
induced complete store emptying, PC12 cells expressing
hUCP4 exhibited reduced SOCE compared with control VT
cells. It is therefore unlikely that the presence of hUCP4 in
mitochondria accelerates refilling of the ER Ca2 stores,
thereby reducing SOCE. Additional data showed that the
decreased SOCE in hUCP4-expressing cells was not attributed
to reduced ER Ca2 store content or increased Ca2 extrusion.
The steady-state mitochondrial Ca2 levels were not signifi-
cantly altered in hUCP4 cells at resting state (Fig. 2, C and D)
suggesting that a moderate dissipation of mitochondrial mem-
brane potential has no significant impact on the trans-mito-
chondrial Ca2 flux responsible for ER refilling (43). Several
studies have demonstrated that functional mitochondria are
essential for maintenance of SOCE in different cell types (16–
19), and dissipation of the mitochondrial membrane potential,
which impairs that ability of mitochondria to buffer cytosolic
Ca2, abolishes Ca2 influx through the SOCE pathway after
the depletion of intracellular Ca2 stores.
FIGURE 7. hUCP4 overexpression suppresses ROS generation and stabilizes mitochondrial function. A, hUCP4 expression attenuates TG-induced
increases in mitochondrial (DHR fluorescence, left panel) and cellular (DCF fluorescence, right panel) ROS levels. Values are the average DHR and DCF fluores-
cence intensity per cell before and after exposure to 0.5 M TG at the indicated time periods (mean  S.D. of determinations made in four to five cultures; 30 – 40
cells assessed in each culture). *, p  0.05. B, hUCP4 attenuates TG-induced mitochondrial hyperpolarization and terminal loss of mitochondrial membrane
potential. Shown are the ratios of the changes in TMRE fluorescence signal (relative to untreated cells) and S.D. of determinations made in three to four cultures
(20 – 40 cells assessed in each culture). *, p  0.05 and **, p  0.01, compared with corresponding values of VT cells. Representative images (right panels)
showing the TMRE fluorescence intensity in VT and hUCP4 cells 6 h after exposure to 0.5 M TG. C, exposure of cells loaded with the synthetic phospholipid
bis-BODIPY-FL-C11-PC to TG triggered rapid cPLA2-mediated phospholipid hydrolysis as indicated by the increase in the intracellular fluorescence signal upon
dequenching of the released labeled phospholipid. Representative images showing the increase in cell-associated fluorescence in VT and hUCP4 cells 15 min
after exposure to TG. D, quantification of BODIPY fluorescence in vehicle-treated cells and TG-treated cells before and 15 min after exposure to TG. Values are
the mean  S.D. of determinations made in three to five cultures. *, p  0.01. Pretreatment with aristolochic acid (Aris, a specific inhibitor of cPLA2: 30 M) or
the SOCE blocker SKF-96365 (SKF, 10 M) for 30 min dramatically diminished the increase in fluorescence signal, consistent with the activation of cPLA2 by TG.
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The exactmechanism of SOCEmodulation bymitochondria
is unknown. In addition to buffering Ca2, mitochondria may
release one or more diffusible factors that regulate SOCE activ-
ity (13–15, 19). A recent study demonstrated that mitochon-
drial localization is also an important determinant of SOCE,
because relocalization of mitochondria from the subplasma
membrane region to perinuclear areas in HeLa cells overex-
pressing dynamitin caused a significant reduction in SOCE
without impacting the ER Ca2 store content (44). Expression
of hUCP4 had no detectable effect on mitochondrial numbers
or subcellular localization, suggesting that the reduced mito-
chondrial Ca2 buffering in hUCP4 cells could not be ascribed
to a reduction or altered distribution ofmitochondria. Further-
more, protein levels of STIM1 (14, 15) and TRPCs, some of
which are involved in SOCE (12), were comparable in VT and
hUCP4-expressing cells.We therefore propose that the activity
of hUCP4 decreases the ability of mitochondria to sequester
Ca2 entering the cell, resulting in a fast feedback inhibition of
SOCC (16–19). In support for this notion, we found that mito-
chondrial Ca2 uptake is reduced in hUCP4 cells during ago-
nist-induced ER Ca2 release and Ca2 entry by the SOCE
pathway. Similar reductions were seen in hUCP4 cells after
store depletion induced by TG and C2-ceramide. Ca2 uptake
is robust in mitochondria situated close to the membranes,
which provides amechanism for rapid sequestration of Ca2 by
mitochondria near plasma membrane and ER Ca2 channels.
However, massive Ca2 uptake by mitochondria, which can
occur during excitotoxic injury and ischemia, can trigger cell
death. Recent studies showed that high levels of UCP2 are asso-
ciatedwith increased resistance of neurons to excitotoxicity (4),
suggesting that a decrease in neuronal mitochondrial mem-
brane potential can suppress Ca2 overload during excitotoxic
insults. Consistent with this,Mattiasson et al. (5) demonstrated
that transgenic mice overexpressing human UCP2 are more
resistant to ischemic brain damage compared with nontrans-
genic control animals, and overexpression of UCP2 in cultured
neurons protects them against oxygen/glucose deprivation-in-
duced death. The latter study also showed that mild mitochon-
drial uncoupling by treatment with 2,4-dinitrophenol prevents
the release of pro-apoptotic factors during oxygen-glucose dep-
rivation and reduces neuronal death.
We found that expression of hUCP4 protects against Ca2
store depletion-induced death following exposure to TG and
C2-ceramide. Studies in other cell systems showed that TG tox-
icity results primarily from mitochondrial Ca2 overload and
secondarily fromER stress associatedwithCa2 store depletion
(45). Expression of hUCP4 blocked mitochondrial ROS forma-
tion by reducing the initial hyperpolarization and the subse-
quent depolarization of the inner mitochondrial membrane
potential. Hyperpolarization has been attributed to rapidmito-
chondrial Ca2 uptake during exposure of neurons to gluta-
mate and oxygen-glucose deprivation (46).Withmitochondrial
membrane hyperpolarization and extrusions of H ions from
the mitochondrial matrix, the cytochromes within the electron
transport chain becomes more reduced, which favors genera-
tion of ROS (47). The early hyperpolarization coincides with
peak generation of ROS (Fig. 7, A and B). ROS are key inducers
ofmitochondrial permeability transition pore opening, and this
process can trigger release of apoptogenic factors and activa-
tion of caspases (48). In addition to themitochondrially derived
ROS, expression of hUCP4 also blocked cPLA2 activation and
subsequent oxidative metabolism of phospholipid-derived
arachidonic acid via the cyclooxygenase or lipoxygenase path-
ways, which leads to O2. or OH production (39). Recent inves-
tigations have demonstrated that members of the UCP family
can prevent mitochondrial ROS formation, oxidative stress,
and the terminal loss of themitochondrialmembrane potential.
Using gene knock-out models and in vitro systems, several
groups demonstrated that UCP2 decreases cellular oxidative
damage through a reduction in mitochondrial ROS production
(49, 50). The generation of ROS has been clearly established as
a contributor to several neurodegenerative diseases and may
underlie cellular changes seen in aging. Interestingly, targeted
expression of UCP2 to the mitochondria of adult neurons can
extend the life span in the fly by decreasing mitochondrial ROS
production and attenuation of oxidative damage (51). We
found that cells expressing hUCP4 exhibited reduced mito-
chondrial Ca2uptake andROS formation comparedwith con-
trol cells after store depletionwith TG. Cells expressing hUCP4
also exhibited resistance to the toxicity of ceramide, a trigger of
store depletion and activation of the SOCE pathway (32), which
has been implicated in the degeneration of neurons in AD and
related neurodegenerative disorders (52). Excessive production
FIGURE 8. Suppression of Gadd153 induction by RNA interference
reduced vulnerability to store depletion-induced apoptosis. A, vector-
transfected (VT) and hUCP4 cells were pre-treated with 100 nM Gadd153
siRNA (siRNAGadd153) and nonsilencing control siRNA (siRNACTRL) for 14 h prior
to exposure to 0.5 M thapsigargin (TG) or vehicle alone (control). Cells were
harvested 12 h after TG exposure, and lysates were immunoblotted for detec-
tion of endogenous Gadd153 protein, glucose-regulated protein (Grp)78 and
Grp94. The TG-induced increase in the latter two stress proteins was detected
with an anti-KDEL antibody as indicated by the single (Grp94) and double
(Grp78) asterisks. The blot was reprobed with an anti-actin antibody to con-
firm equal levels of protein loading among samples. B, VT and hUCP4 cells
were pre-treated either with 100 nM siRNAs (siRNAGadd153 or siRNACTRL) for 14 h
or with 30 M aristolochic acid (AA) for 2 h prior to exposure to 0.5 M TG or to
vehicle for 12 h. Cells were fixed for quantitation of cell death. For each treat-
ment condition, the percentage of dead cells in the vehicle-treated group
was subtracted from that in the TG-treated group. In the siRNAGadd153-treated
groups, the percentage of dead cells was not significantly different. Values are
the mean  S.D. of four separate cultures per group (150 –200 cells assessed/
culture). *, p  0.05; #, p  0.01, compared with VT cells treated with TG.
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of ceramide may kill cells by triggering the mitochondrial-de-
pendent pathway of apoptosis. The ability of hUCP4 to protect
cells against ceramide-induced death therefore suggests an
important role for this UCP in pathological conditions that
involve ceramide-mediated cell death.
Grp78 is an ER chaperone that plays a critical role in main-
taining cell viability under conditions of ER stress (34, 53).
However, the decreased susceptibility of cells expressing
hUCP4 to store depletion-induced death was not due to an
effect on expression of Grp78, because themagnitude of induc-
tion ofGrp78was similar inVTandhUCP4 cells. The size of the
releasable ER Ca2 pool was also similar in VT and hUCP4
cells, ruling out the possibility that this parameter played a piv-
otal role in determining vulnerability to store depletion-in-
duced death (36). On the other hand, we found that the rapid
and sustained increase in Gadd153 protein level in response to
ER store depletion was attenuated in hUCP4 cells. Gadd153 is a
transcription factor that forms heterodimers with members of
the CAAT/enhancer-binding protein family and is thought to
be responsible for the induction of genes required for cell cycle
arrest and apoptosis (54). The level of Gadd153 is very low
under basal conditions, but its levels increase greatly in
response toDNAdamage andER stress (54–56). Previous stud-
ies have shown that TG and ionophores induce transcriptional
activation of Gadd153 by elevating [Ca2]i (35), and induction
of Gadd153 may be required for release of cytochrome c from
mitochondria and caspase activation (57). Gadd153 expression
is also induced by oxidative stress (40–42), and the age-related
increase in Gadd153 expression is correlated with heightened
sensitivity to oxidant injury (58). Increased Gadd153 expres-
sion also mediates dopaminergic death following intrastriatal
injection of 6-hydroxydopamine (59), a hydroxylated dopamine
analogue that is readily oxidized causing oxidant injury. It
remains to be determined whether the neuroprotective action
of UCP2 in a mouse model of Parkinson disease (60) involves
the suppression of Gadd153 induced by 1-methyl-4-phe-
nylpyridinium (61). Because store depletion produces oxidative
stress, which in turn induces Gadd153 expression, and because
store depletion-induced death was significantly reduced by
knockdown of Gadd153 expression, our data suggest that
hUCP4may contribute to the cytoprotective effect by reducing
the up-regulation of oxidative stress-inducible and pro-apopto-
tic genes.
Collectively, our data provide evidence that hUCP4 can reg-
ulate Ca2 homeostasis and signaling, apparently by reducing
mitochondrial membrane potential and Ca2 sequestration,
the latter process playing an important role in SOCE. hUCP4
expression did not affect Bcl-2 expression but did reduce store
depletion-induced oxidative stress and Gadd153 expression.
Because ER stress, whether it results from protein misfolding
and aggregation or from ischemic injury, inevitably leads to
Ca2 store depletion (62), enhancing neuronal UCP function
may prove to be a valuable protective strategy to counteract
mitochondrial Ca2 overload and loss of mitochondrial func-
tion that precedes neurodegeneration. Future studies will
determine if abnormalities in UCP4 expression or function
contribute to the dysfunction and degeneration of neurons in
acute and chronic neurodegenerative disorders.
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